期刊文献+

sRAGE对缺氧/复氧心肌细胞氧化应激的影响 被引量:7

Influence of soluble form of receptor for advanced glycation end products(sRAGE) on hypoxia/reoxygenation myocardial oxidative stress
下载PDF
导出
摘要 目的观察可溶性晚期糖基化终产物(soluble form of receptor for advanced glycation end products,sRAGE)对缺氧/复氧心肌细胞氧化应激的影响。方法乳鼠心肌细胞原代培养48 h,以低氧3 h、复氧2 h复制缺氧/复氧损伤模型,采用抽签法将乳鼠心肌细胞随机分为4组:常氧对照组(Control,Con)、常氧+sRAGE组(Con-sRAGE)、缺氧/复氧组(Hypoxia/reoxygenation,H/R))、缺氧/复氧+sRAGE组(H/R-sRAGE)。采用四甲基偶氮唑蓝〔3(4,5-dimethyl-thiazol)-2,5-diphenyl-tetrazolium,MTT〕比色法检测心肌细胞活力和培养液中乳酸脱氢酶(lactate dehydrogenase,LDH)浓度,黄嘌呤氧化酶法测定超氧化物歧化酶(superoxide dismutase,SOD)活力,硫代巴比妥酸显色法测定丙二醛(malondialdehyde,MDA)含量,2',7'-二氯荧光黄双乙酸盐(DCFH-DA)荧光探针联合流式细胞仪检测细胞荧光强度-反应活性氧(reactive oxygen species,ROS)水平,硝酸还原酶法测定一氧化氮(nitric oxide,NO)含量。结果与H/R组相比,H/R-sRAGE组可以提高心肌细胞活力,减少LDH漏出量,增加SOD活力,降低MDA、ROS、NO含量(P<0.05)。结论 sRAGE可以直接作用于心肌细胞拮抗缺氧/复氧损伤,其保护性作用与抑制氧化应激有关。 To elucidate the influence of soluble form of receptor for advanced glycation end products (sRAGE) on hypoxia/reoxygenation myocardial oxidative stress. Methods Cardiac myocytes were isolated from neonatal rats with the modified 2-step collagenase digest method and were subjected to Primary culture for 48 hours. Hypoxia 3 h/reoxygenation 2 h injury model was produced. The cells were randomly divided into four groups : normoxic control group ( Con), normoxia + sRAGE group ( Con-sRAGE ), hypoxia/ reoxygenation (H/R) group( model group) , hypoxia/reoxygenation + sRAGE (H/R-sRAGE) group ( experimental group). The viability of myocardial cells was detected by M'I~ ; The leakage of lactate dehydrogenase in culture medium ( LDH ) ; the activity of superoxide dismutase (SOD) were detected by xanthine oxidase; The content of malondialdehyde (MDA) was detected by thiobarbituric acid color method; The intensity of fluorescence was detected by DCFH-DA fluorescent probe combined flow cytometry-Reactive oxygen species (ROS) levels in response; nitrate reductase determination of nitric oxide (NO) levels. Results Compared with H/R group, H/R- sRAGE group could improve the myocardial viability, reduce the amount of LDH leakage, increase SOD activity, lower MDA and ROS levels (P〈0.05). Conclusion sRAGE may act directly on myocardial cells and antagonize the hypoxia/reoxygenation injury, the protective role is related to inhibition of oxidative stress.
出处 《首都医科大学学报》 CAS 2012年第4期488-493,共6页 Journal of Capital Medical University
基金 国家自然科学基金项目(30801217) 北京市科技新星课题(2010B050)~~
关键词 SRAGE 心肌细胞 缺氧/复氧 氧化应激 soluble form of receptor for advanced glycation end products myocardial cells hypoxia/reoxygenation oxidative stress
  • 相关文献

参考文献15

  • 1Zhao Z Q, Corvera J A, Halkos M E, et al. Inhibition of myocardial injury by ischemic postconditioning during reper- fusion : comparison with ischemic preconditioning [ J ]. Am J Physiol Heart Circ Physia|, 2003,285 (2) : H579 - 588. 被引量:1
  • 2Tam X H, Shiu S W, Leng L, et al. Enhanced expression of receptor for advanced glycation end-products is associated with low circulating soluble isoforms of the receptor in Type 2diabetes[J]. ClinSci (Lond), 2011,120(2): 81-89. 被引量:1
  • 3Mauri T, Masson S, Pradella A, et al. Elevated plasma and alveolar levels of soluble receptor for advanced glycation endproducts are associated with severity of lung dysfunction in ARDS patients[J]. Tohoku J Exp Med, 2011, 222(2) : 105 - 112. 被引量:1
  • 4Yan S F, Yan S D, Ramasamy R, et al. Tempering the wrath of RAGE : an emerging therapeutic strategy against diabetic complications, neurodegeneration, and inflammation [J3. Ann Med, 2009, 41(6): 408 -422. 被引量:1
  • 5Raposeiras-Roubin S, Rodino-Janeiro B K, Grigorian-sham- agian L, et al. Relation of soluble receptor for advanced glycation end products to predict mortality in patients with chronic heart failure independently of Seattle Heart Failure Score[J]. Am J Cardiol, 2011, 107(6) : 938 -944. 被引量:1
  • 6Jiao L, Taylor P R, Weinstein S J, et al. Advanced glyca- tion end products, soluble receptor for advanced glycation end products, and risk of colorectal cancer[ J l- Cancer Ep- idemiol Biomarkers Prev, 2011, 20(7) : 1430- 1438. 被引量:1
  • 7Bucciarelli L G, Kanekom, Ananthakrishnan R, et al. Re- ceptor for advanced-glycation end products: key modulator of myocardial ischemic injury[J]. Circulation, 2006. 113 (9) : 1226 - 1234. 被引量:1
  • 8董洪武,郭彩霞,杜凤和,王红霞,曾翔俊,张立克,田俊萍.缺血/再灌注损伤对大鼠心肌内源性可溶性糖基化终末产物受体分泌的影响[J].首都医科大学学报,2011,32(5):640-644. 被引量:6
  • 9郭军,鲍翠玉,林国生,杨波.新生大鼠心肌细胞培养方法的改进[J].心血管康复医学杂志,2006,15(6):538-540. 被引量:13
  • 10李卓,谷天祥,张玉海.兔改良心肌缺血模型的建立[J].中国医科大学学报,2010,39(9):740-742. 被引量:3

二级参考文献14

  • 1Suzuki Y, Oyane A, Ikeno F, et al. Development of animal model for calcified chronic total occlusion [Jl. Catheter Cardiovasc Interv,2009, 74 (3):468-475. 被引量:1
  • 2Noort WA,Feye D,Van Den Akker F,et al. Mesenchymal stromal cells to treat cardiovascular disease:strategies to improve survival and therapeutic results[J]. Panminerva Med,2010,52( 1 ) :27-40. 被引量:1
  • 3Kawada T,Akiyama T,Shimizu S,et al. Detection of endogenous acetylcholine release during brief ischemia in the rabbit ventricle:a possible trigger for ischemic preconditioning [J]. Life Sci,2009,85(15-16) : 597-601. 被引量:1
  • 4Ben-Dor I, Hardy B, Fuchs S, et al. Repeated low-dose of erythropoietin is associated with improved left ventricular function in rat acute myocardial infarction model [J ]. Cardiovasc Drugs Ther,2007 ,21( 5 ) : 339-346. 被引量:1
  • 5Spinale FG, Coker ML, Bond BR, et al. Myocardial matrix degradation and metalloproteinase activation in the failing heart:a potential therapeutic target [J].Cardiovasc Res, 2000,46 ( 2 ) : 225-238. 被引量:1
  • 6Bes S,Roussel P,Laubriet A,et al.Influence of deep hypothermia on the tolerance of the isolated cardiomyocyte to ischemia-reperfusion[J].J Mol Cell Cardiol,2001,33(11):1973-1988. 被引量:1
  • 7Suzuki T,Ohata M,Hosh H.Serum free,chemically defined medium to evaluate the direct effects of growth factors and inhibitors on proliferation and function of neonatal rat cardiac muscle cells in culture[J].In Vitro,1989,25(7):601-606. 被引量:1
  • 8Li C,Cao L,Zheng Q,et al.Taurine may prevent diabetic rats from developing cardiomyopathy also by downregulating angiotensin Ⅱtype 2 receptor expression[J].Cardiovasc Drugs Ther,2005,19(2):105-120. 被引量:1
  • 9Acostal D,Li CP.Injury to primary cutures of rat heart endothelial cells by hypoxia and glucose deprivation[J].In Vitro,1979,15(11):929-934. 被引量:1
  • 10陈婷婷,李力兵,王刚,高长青.不同呼吸管理模式下大鼠急性心梗模型远期存活率的比较及影响因素分析[J].中国体外循环杂志,2008,6(1):43-46. 被引量:2

共引文献30

同被引文献79

  • 1吴锦晖,张新军,吴琳娜.NF-κB在慢性心力衰竭发病机制中的研究[J].华西医学,2007,22(4):925-926. 被引量:7
  • 2刘争杰,朱红霞,赵自刚,牛春雨.晚期糖基化终末产物受体在疾病发展进程中的作用[J].中国老年学杂志,2014,34(7):1995-1997. 被引量:2
  • 3邵亚辉,许顶立.糖基化终极产物对心血管系统的损伤作用及干预措施[J].中国分子心脏病学杂志,2004,4(4):253-256. 被引量:7
  • 4Aleshin A. RAGE modulates myocardial injury consequent to LAD infarction via impact on JNK and STAT signaling in a murine model [JJ. Am J Physiol Heart Circ Physiol, 2008,294 (4):H1823- 1832. 被引量:1
  • 5Sternberg D. Blockade of receptor for advanced glycation end prod- uct attenuates pulmonary reperfusion injury in mice [ J ]. Thorac Car- diovasc Surg, 2008,136 (6) : 1576-1585. 被引量:1
  • 6Zeng S. Blockade of receptor for advanced glycation end product (RAGE) attenuates ischemia and reperfusion injury to the liver in mice[ J. Hepatology, 2004,39 (2) :422-432. 被引量:1
  • 7Halestrap AP. What is the mitochondrial permeability transition pore [ J ]. Journal of Molecular and Cellular Cardiology, 2009,46 ( 6 ) : 821-831. 被引量:1
  • 8Nishihara M, Miura T, Miki T, et al. Modulation of the mitochon- drial permeability transition pore complex inGSK-3β-mediated myo- cardial protection [ J ]. J Mol Cell Cardiol, 2007,43 ( 5 ) : 564 -570. 被引量:1
  • 9Lim SY, Davidson SM, Hausenloy DJ, et al. Preconditioning and postcondflioning: the essential role of the mitochondrial permeability transition pore[ J]. Cardiovasc Res, 2007,75 (3) :530-535. 被引量:1
  • 10Yellon DM, Hausenloy DJ. Myocardial reperfusion injury [ J ]. N Engl J Med, 2007,357(11) :1121-1135. 被引量:1

引证文献7

二级引证文献49

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部